Immatics (IMTX) Net Cash Flow (2019 - 2025)
Immatics (IMTX) posted Net Cash Flow of $13.9 million for Q4 2025, down 84.57% sequentially from $90.3 million in Q3 2025, and down 67.8% YoY from $43.3 million in Q4 2024.
Immatics (IMTX) Net Cash Flow (2019 - 2025) Analysis & Trends
Immatics has reported Net Cash Flow for 7 years, with the latest figure at $13.9 million in Q4 2025.
- Quarterly Net Cash Flow fell 67.8% year-over-year to $13.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.4 million (up 1437.13% YoY) and the FY2025 annual result came in at $141.8 million, up 1313.83% from the prior year.
- Net Cash Flow fell to $13.9 million in Q4 2025 per IMTX's latest filing, from $90.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $148.3 million in Q4 2023 and troughed at -$108.4 million in Q1 2024.
- A 5-year average of $8.2 million and a median of $11.5 million in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow slumped 1905.08% in 2022, then soared 999.38% in 2023.
- Over 5 years, Net Cash Flow stood at -$31.7 million in 2021, then soared by 47.92% to -$16.5 million in 2022, then soared by 999.38% to $148.3 million in 2023, then slumped by 70.84% to $43.3 million in 2024, then slumped by 67.8% to $13.9 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered $13.9 million, $90.3 million, and $27.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 13.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.93 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Sep 30, 2023 | -55.73 Mn |
| Sep 30, 2023 | -55.73 Mn |